欧盟EMA药品数据库-欧盟集中审批药品
(European Medicines Agency Authorisation of Medicines DataBase)
商品名称 适用类别 通用名称 活性成分 产品号 上市许可开发者/申请人/持有人 上市许可日期 许可状态
Vyloy Human zolbetuximab zolbetuximab EMEA/H/C/005868 Astellas Pharma Europe B.V. 2024/09/19 Authorised
Tuznue Human trastuzumab trastuzumab EMEA/H/C/006252 Prestige Biopharma Belgium 2024/09/19 Authorised
Anzupgo Human delgocitinib Delgocitinib EMEA/H/C/006109 LEO Pharma A/S 2024/09/19 Authorised
Epruvy (previously Ranibizumab Midas) Human ranibizumab ranibizumab EMEA/H/C/006528 Midas Pharma GmbH 2024/09/19 Authorised
Axitinib Accord Human axitinib axitinib EMEA/H/C/006206 Accord Healthcare S.L.U. 2024/09/19 Authorised
Iqirvo Human elafibranor Elafibranor EMEA/H/C/006231 Ipsen Pharma 2024/09/19 Authorised
Kayfanda Human odevixibat odevixibat sesquihydrate EMEA/H/C/006462 Ipsen Pharma 2024/09/19 Authorised
Ituxredi Human rituximab rituximab EMEA/H/C/006224 Reddy Holding GmbH 2024/09/19 Authorised
Vevizye Human ciclosporin ciclosporin EMEA/H/C/006250 Laboratoires Théa 2024/09/19 Authorised
Eksunbi Human ustekinumab ustekinumab EMEA/H/C/006448 Samsung Bioepis NL B.V. 2024/09/12 Withdrawn
mResvia Human respiratory syncytial virus mRNA vaccine Single-stranded 5' capped mRNA encoding the respiratory syncytial virus glycoprotein F stabilised in the prefusion conformation EMEA/H/C/006278 Moderna Biotech Spain, S.L. 2024/08/22 Authorised
Balversa Human erdafitinib Erdafitinib EMEA/H/C/006050 Janssen-Cilag International N.V. 2024/08/22 Authorised
Steqeyma Human ustekinumab ustekinumab EMEA/H/C/005918 Celltrion Healthcare Hungary Kft. 2024/08/22 Authorised
Eurneffy Human epinephrine epinephrine EMEA/H/C/006139 ALK-Abelló A/S 2024/08/22 Authorised
Winrevair Human sotatercept sotatercept EMEA/H/C/005647 Merck Sharp & Dohme B.V. 2024/08/22 Authorised
Enzalutamide Viatris Human enzalutamide enzalutamide EMEA/H/C/006299 Viatris Limited 2024/08/22 Authorised
Piasky Human crovalimab Crovalimab EMEA/H/C/006061 Roche Registration GmbH 2024/08/22 Authorised
Tauvid Human flortaucipir (18F) Flortaucipir (18F) EMEA/H/C/006064 Eli Lilly Nederland B.V. 2024/08/22 Authorised
Ordspono Human odronextamab odronextamab EMEA/H/C/006215 Regeneron Ireland Designated Activity Company (DAC) 2024/08/22 Authorised
Nilotinib Accord Human nilotinib nilotinib EMEA/H/C/006315 Accord Healthcare S.L.U. 2024/08/22 Authorised

数据库说明:

©2006-2026 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase